InvestorsObserver
×
News Home

Will Galera Therapeutics Inc (GRTX) Stay at the Top of the Healthcare Sector?

Friday, March 31, 2023 04:00 PM | InvestorsObserver Analysts

Mentioned in this article

Will Galera Therapeutics Inc (GRTX) Stay at the Top of the Healthcare Sector?

Galera Therapeutics Inc (GRTX) is near the top in its sector according to InvestorsObserver. GRTX gets an overall rating of 75. That means it scores higher than 75% of stocks. Galera Therapeutics Inc gets a 97 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

Overall Score - 75
GRTX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on GRTX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Galera Therapeutics Inc Stock Today?

Galera Therapeutics Inc (GRTX) stock is trading at $2.56 as of 4:00 PM on Friday, Mar 31, a rise of $0.12, or 4.92% from the previous closing price of $2.44. The stock has traded between $2.44 and $2.61 so far today. Volume today is below average. So far 503,362 shares have traded compared to average volume of 1,043,017 shares. Click Here to get the full Stock Report for Galera Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App